> NextDocs, a provider of data management for drug developers, scooped up $5 million in a round of financing after grabbing a $10 million round of growth equity from OpenView Venture Partners two years ago. Item
> Signal Genetics touted results from a Weill Cornell study of its algorithms for providing prognoses for cases of breast cancer. Release
> Here's a case study of Merck's ($MRK) use of an electronic lab notebook from PerkinElmer. Item